Skip to main content
Log in

Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Conclusions

In summary, the LOS of B. pertussis lacks the long-chain polysaccharide O antigen, and is resolved electrophoretically into two distinct bands designated LOS A and LOS B. Mice administered with anti-LOS A mAbs can be protected from fatal B. pertussis infection. These observations may indicate potential for oligosaccharides as a component of new acellular pertussis vaccines. Studies performed thus far also suggest that idiotypic profiles influence the protective value of antibodies and that several antibody-mediated effector functions may participate in the protection. Further research investigating the factors inducing protective immunity is needed for a better definition of new vaccine formulations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ackers JP, Dolby JM (1972) The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection in mice. J Gen Microbiol 70:371

    Google Scholar 

  2. Amano KI, Fukushi K, Watanabe M (1990) Biochemical and immunological comparison of lipopolysaccharides from Bordetella species. J Gen Microbiol 136:481

    Google Scholar 

  3. Aprile MA, Wardlaw AC (1973) Immunochemical studies on the lipopolysaccharides of Bordetella pertussis. Can J Microbiol 19:231

    Google Scholar 

  4. Archambault D, Rondeau P, Martin D, Brodeur BR (1991) Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide A. J Gen Microbiol 137:905

    Google Scholar 

  5. Arciniego JL, Hewlett EL, Johnson FD, Deforest A, Wassilak SGF, Onorato IM, Manclark CR, Burns DL (1991) Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis 163:135

    Google Scholar 

  6. Armstrong SK, Parker CD (1986) Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation. Infect Immun 54:308

    Google Scholar 

  7. Ashworth LAE, Fitzgeorge RB, Irons LI, Morgan CP, Robinson A (1982) Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels. J Hyg 88:475

    Google Scholar 

  8. Ashworth LAE, Robinson A, Irons LI, Morgan CP (1983) Antigens in whooping cough vaccine and antibody levels induced by vaccination of children. Lancet II:878

    Google Scholar 

  9. Ayme G, Caroff M, Chaby R, Haeffner-Cavaillon N, LeDur A, Moreau M, Muset M, Mynard MC, Roumiantzeff M, Schulz D, Szabo L (1980) Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties. Infect Immun 27:739

    Google Scholar 

  10. Briles DE, Forman C, Hudak S, Claflin JL (1982) Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 156:1177

    Google Scholar 

  11. Brodeur BR, Hamel J, Martin D, Rondeau P (1991) Biological activity of a human monoclonal antibody to Bordetella pertussis lipooligosaccharide. Hum Antibod Hybridomas 2:194

    Google Scholar 

  12. Caroff M, Lebbar S, Szabo L (1987) Detection of 3-deoxy-2-octulosonic acid in thiobarbiturate negative endotoxins. Carbohydr Res 161:c4

    Google Scholar 

  13. Caroff M, Chaby R, Karibian D, Perry J, Deprun C, Szabo L (1990) Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features. J Bacteriol 172:1121

    Google Scholar 

  14. Cherry JD, Brunell PA, Golden GS, Karzon DT (1988) Report of the task force on pertussis and pertussis immunization-1988. Pediatrics 81:939

    Google Scholar 

  15. Cody CL, Baraff J, Cherry JD, Marcy SM, Manclark CR (1981) Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 68:650

    Google Scholar 

  16. Coote JG (1991) Antigenic switching and pathogenicity: environmental effects on virulence gene expression in Bordetella pertussis. J Gen Microbiol 137:2493

    Google Scholar 

  17. Corbel MJ, Abraham AM (1992) Agglutination of Bordetella species by lectins. FEMS Microbiol Letters 90:245

    Google Scholar 

  18. Dolby JM, Ackers JP (1975) Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis. J Gen Microbiol 87:239

    Google Scholar 

  19. Dolby JM, Dolby DE (1969) The antibody activities of 19S and 7S fractions from rabbit antisera to Bordetella pertussis. Immunol 16:737

    Google Scholar 

  20. Edwards KM, Karzon DT (1990) Pertussis vaccines. Pediatr Clin North Am 37:549

    Google Scholar 

  21. Gotto J, Eckhardt T, Scott J, Woods D (1992) Protective effect of Bordetella pertussis lipopolysaccharide in the rat intratracheal challenge model of pertussis. Abstracts of the 92nd Annual Meeting of the American Society for Microbiology. ASM, New Orleans, p 146

    Google Scholar 

  22. Hamel J, Cazeault C, Brodeur BR (1992) Idiotypic analysis of a protective anti-B. pertussis LOS monoclonal antibody. Abstracts of the 92nd Annual Meeting of the American Society for Microbiology. ASM, New Orleans, p 121

    Google Scholar 

  23. Holst O, Brade H (1992) Chemical structure of the core region of lipopolysaccharides. In: Morrison DC, Ryan JL (eds) Bacterial endotoxic lipopolysaccharides, vol 1. CRC Press, Ann Arbor, pp 135–170

    Google Scholar 

  24. Kasuga T, Nakase Y, Ukishima K, Takatsu K (1954) Studies on Haemophilus pertussis. III. Some properties of each phase of H. pertussis. Kitasato Arch Exp Med 27:37

    Google Scholar 

  25. Lacey BW (1960) Antigenic modulation of Bordetella pertussis. J Hyg 58:57

    Google Scholar 

  26. LeDur A, Caroff M, Chaby R, Szabo L (1978) A novel type of endotoxin structure present in Bordetella pertussis. Isolation of two different polysaccharides bound to lipid A. Eur J Biochem 84:579

    Google Scholar 

  27. Leslie PH, Gardner AD (1931) The phases of Haemophilus pertussis. J Hyg Camb 31:423

    Google Scholar 

  28. Li ZM, Cowell JL, Brennan MJ, Burns DL, Manclark CR (1988) Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun 56:699

    Google Scholar 

  29. MacLennan AP (1960) Specific lipopolysaccharides of Bordetella. Biochem J 74:398

    Google Scholar 

  30. Manclark CR, Cowell JL (1984) Pertussis. In: Germanier R (ed) Bacterial vaccines. Academic Press, New York, pp 69–106

    Google Scholar 

  31. Martin D, Peppler MS, Brodeur BR (1992) Immunological characterization of the lipooligosaccharide B band of Bordetella pertussis. Infect Immun 60:2718

    Google Scholar 

  32. McPheat WL, Wardlaw AC, Novotny P (1983) Modulation of Bordetella pertussis by nicotinic acid. Infect Immun 41:516

    Google Scholar 

  33. Miller DL, Ross EM, Alderslade R, Bellman MH, Rawson NSB (1981) Pertussis immunization and serious acute neurological illness in children. Br Med J 282:1595

    Google Scholar 

  34. Moreau M, Chaby R, Szabo L (1984) Structure of the terminal reducing heptasaccharide of polysaccaride 1 isolated from the Bordetella pertussis endotoxin. J Bacteriol 159:611

    Google Scholar 

  35. Mortimer EA (1988) Pertussis vaccine. In: Plotkin SA, Mortimer EA (eds) Vaccines. WB Saunders, Philadelphia, pp 74–96

    Google Scholar 

  36. Mortimer EA Jr (1990) Pertussis and pertussis vaccine. Adv Pediatr Infect 5:1

    Google Scholar 

  37. Mortimer EA, Jones PK (1979) An evaluation of pertussis vaccine. Rev Infect Dis 1:927

    Google Scholar 

  38. Mountzouros KT, Kimura A, Cowell JL (1992) A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosal infection with B. pertussis. Infect Immun 60:5316

    Google Scholar 

  39. Musser JM, Hewlett EL, Peppler MS, Selander RK (1986) Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol 166:230

    Google Scholar 

  40. Nakase Y, Tateisi M, Sekiya K, Kasuga T (1970) Chemical and biological properties of the purified O antigen of Bordetella pertussis. Jpn J Microbiol 14:1

    Google Scholar 

  41. Peppler MS (1984) Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants. Infect Immun 43:224

    Google Scholar 

  42. Pusztai Z, Csizér Z, Joo I (1971) The role and specificity of Bordetella lipopolysaccharide in immune reactions. Z Immunitätsforsch 141:129

    Google Scholar 

  43. Ray A, Redhead K, Selkirk S, Poole S (1991) Variability in LPS composition, antigenicity and reactogenicity of phase variants of Bordetella pertussis. FEMS Microbiol Lett 79:211

    Google Scholar 

  44. Romanus V, Jonsell R, Bergquist SO (1987) Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J 6:364

    Google Scholar 

  45. Shahin RD, Brennan MJ, Li ZM, Meade BD, Manclark CR (1990) Characterization of the protective capacity and immunogenicity of the 69kd outer membrane protein of Bordetella pertussis. J Exp Med 171:63

    Google Scholar 

  46. Shahin RD, Hamel J, Brodeur BR, Leef MF (1992) Analysis of protective and non-protective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide. Abstracts of the 92nd Annual Meeting of the American Society for Microbiology. ASM, New Orelans, p 121

    Google Scholar 

  47. Szabo P, Szabo L (1991) Synthesis of 2-deoxy-4-O-α-and-β-d-mannopyranosyl-l-erythropentonic acids. Carbohydr Res 216:245

    Google Scholar 

  48. Walsh JA, Warren KS (1979) Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med 301:967

    Google Scholar 

  49. Wardlaw AC, Parton R (1983) Bordetella pertussis toxins. Pharmacol Ther 19:1

    Google Scholar 

  50. Watanabe M, Takimoto H, Kumazawa Y, Amano KI (1990) Biological properties of lipopolysaccharides from Bordetella species. J Gen Microbiol 136:489

    Google Scholar 

  51. Weiss AA, Hewlett EL (1986) Virulence factors of Bordetella pertussis. Annu Rev Microbiol 40:661

    Google Scholar 

  52. Weiss AA, Hewlett EL, Myers EG, Falkow S (1983) Tn-5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun 42:33

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brodeur, B.R., Martin, D., Hamel, J. et al. Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis . Springer Semin Immunopathol 15, 205–215 (1993). https://doi.org/10.1007/BF00201101

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00201101

Keywords

Navigation